本页面由Tiger Trade Technology Pte. Ltd.提供服务

Royalty Pharma plc

57.78
+0.85001.49%
盘后:57.780.00000.00%19:30 EDT
成交量:246.53万
成交额:1.42亿
市值:333.35亿
市盈率:30.99
高:57.92
开:57.04
低:56.85
收:56.93
52周最高:64.38
52周最低:35.23
股本:5.77亿
流通股本:3.93亿
量比:0.78
换手率:0.63%
股息:0.91
股息率:1.58%
每股收益(TTM):1.86
每股收益(LYR):1.78
净资产收益率:13.97%
总资产收益率:5.09%
市净率:4.88
市盈率(LYR):32.44

数据加载中...

2026/10/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities